Granules India Limited

Granules India Limited Granules India Limited is generic pharmaceutical company headquartered in Hyderabad, India.

Team Granules wishes everyone a happy and healthy Easter!
05/04/2026

Team Granules wishes everyone a happy and healthy Easter!

As we welcome a new year filled with new beginnings, may your home be filled with happiness, prosperity, and good health...
19/03/2026

As we welcome a new year filled with new beginnings, may your home be filled with happiness, prosperity, and good health.

Wishing you a joyful and prosperous celebration.

Happy Ugadi from Team Granules

We are delighted to share that Granules India Limited has been placed on the CDP Supplier Engagement Assessment (SEA) A‑...
03/03/2026

We are delighted to share that Granules India Limited has been placed on the CDP Supplier Engagement Assessment (SEA) A‑List, marking our second consecutive year of recognition with an overall score of “A”. This places us among a select group of global companies recognized for exceptional leadership in climate action across the value chain.

Our 2025 CDP Ratings:
CDP Supplier Engagement Assessment (SEA) 2025: A
CDP Climate Change 2025: A
CDP Water Security 2025: B
CDP Forests 2025: B‑

This recognition highlights our strong governance practices, science‑aligned target setting, Scope 3 emissions management, and deep engagement across our value chain, all evaluated through the CDP Climate Change framework.

We are happy to share that Ms. Yamuna Kumari K, a beneficiary of the Granules Vidya Scholarship’s first batch, has been ...
13/02/2026

We are happy to share that Ms. Yamuna Kumari K, a beneficiary of the Granules Vidya Scholarship’s first batch, has been selected in the Andhra Pradesh Public Service Commission (APPSC), Government of Andhra Pradesh Group–1 Cadre.

Yamuna always aspired to pursue higher education and dreamt of a government job. Despite financial challenges, she stayed committed to her goal and prepared for the civil services.

With support from our CSR initiative for civil service aspirants in Andhra Pradesh and Telangana, Yamuna received financial assistance, study material, mentorship, and expert coaching, which helped turning her dreams into reality.

To celebrate this milestone, Mrs. Uma Chigurupati, Executive Director at Granules India Limited congratulated her personally. She shared, "Granules takes pride in contributing to journeys like Yamuna’s and nurturing future leaders who will serve the country.”

At Granules India Limited, progress in science is driven by expertise, discipline, and diverse thinking. Today, we celeb...
11/02/2026

At Granules India Limited, progress in science is driven by expertise, discipline, and diverse thinking. Today, we celebrate the women whose work in our research labs, quality functions, and on our manufacturing floors, continues to shape a more inclusive and sustainable future in science.

Our Executive Director, Ms. Priyanka Chigurupati along with the leadership team launched 𝐆𝐫𝐚𝐧𝐮𝐥𝐞𝐬 𝐂𝐚𝐫𝐞 𝐂𝐡𝐫𝐨𝐧𝐢𝐜𝐥𝐞, 𝐨𝐮𝐫 𝐧𝐞...
04/02/2026

Our Executive Director, Ms. Priyanka Chigurupati along with the leadership team launched 𝐆𝐫𝐚𝐧𝐮𝐥𝐞𝐬 𝐂𝐚𝐫𝐞 𝐂𝐡𝐫𝐨𝐧𝐢𝐜𝐥𝐞, 𝐨𝐮𝐫 𝐧𝐞𝐰 𝐄𝐇𝐒 & 𝐒𝐮𝐬𝐭𝐚𝐢𝐧𝐚𝐛𝐢𝐥𝐢𝐭𝐲 𝐧𝐞𝐰𝐬𝐥𝐞𝐭𝐭𝐞𝐫 𝐟𝐨𝐫 𝐨𝐮𝐫 𝐞𝐦𝐩𝐥𝐨𝐲𝐞𝐞𝐬 that captures the progress, people, and new initiatives driving Granules forward.

From safety milestones and site innovations to global ESG recognitions and sustainability wins, every edition will focus on the actions that strengthen our commitment to Our Purpose of ‘𝙃𝙚𝙖𝙡𝙞𝙣𝙜 𝙇𝙞𝙫𝙚𝙨 𝙍𝙚𝙨𝙥𝙤𝙣𝙨𝙞𝙗𝙡𝙮 𝙏𝙝𝙧𝙤𝙪𝙜𝙝 𝙋𝙞𝙤𝙣𝙚𝙚𝙧𝙞𝙣𝙜 𝙂𝙧𝙚𝙚𝙣 𝙎𝙘𝙞𝙚𝙣𝙘𝙚.’

 Granules India Limited is building its next operating layer — powered by AI. Across pharma and life sciences, AI is mov...
02/02/2026



Granules India Limited is building its next operating layer — powered by AI.

Across pharma and life sciences, AI is moving from experiments to ex*****on. At Granules, we are taking that shift seriously. We are not treating AI as a side initiative or a lab-only function, we are working toward infusing AI across R&D, manufacturing, quality, and enterprise workflows. That means agentic systems that reason, act, and integrate with real production environments. Multimodal AI that understands text, data, voice, and visuals. And platforms that turn these capabilities into reliable, scalable tools for real users.

As part of this push, 𝘄𝗲 𝗮𝗿𝗲 𝗲𝘅𝗽𝗮𝗻𝗱𝗶𝗻𝗴 𝗼𝘂𝗿 𝗰𝗼𝗿𝗲 𝗔𝗜 𝗲𝗻𝗴𝗶𝗻𝗲𝗲𝗿𝗶𝗻𝗴 𝘁𝗲𝗮𝗺 𝗮𝗻𝗱 𝗵𝗶𝗿𝗶𝗻𝗴 𝗳𝗼𝗿 𝘁𝗵𝗿𝗲𝗲 𝗳𝗼𝘂𝗻𝗱𝗮𝘁𝗶𝗼𝗻𝗮𝗹 𝗿𝗼𝗹𝗲𝘀:

• 𝗔𝗜 𝗘𝗻𝗴𝗶𝗻𝗲𝗲𝗿 – 𝗔𝗴𝗲𝗻𝘁𝗶𝗰 𝗦𝘆𝘀𝘁𝗲𝗺𝘀 - designing and operating LLM-driven autonomous and multi-agent systems used across enterprise workflows

• 𝗔𝗜 𝗘𝗻𝗴𝗶𝗻𝗲𝗲𝗿 – 𝗠𝘂𝗹𝘁𝗶𝗺𝗼𝗱𝗮𝗹 - developing real-time multimodal AI systems spanning language, audio, vision, and human-like interaction

• 𝗦𝗲𝗻𝗶𝗼𝗿 𝗙𝘂𝗹𝗹-𝗦𝘁𝗮𝗰𝗸 𝗘𝗻𝗴𝗶𝗻𝗲𝗲𝗿 - building clean, high-performance B2B platforms that translate complex AI systems into intuitive, production-grade experiences

If you are motivated by building real-world AI applications in a regulated, high-impact environment, Granules offers an opportunity to contribute pharmaceutical manufacturing being reimagined through technology.

Interested candidates may apply on Sreeram.Gogineni@granulesindia.com

Granules India Limited is pleased to collaborate with the Society for Elimination of Rural Poverty (SERP), Government of...
28/01/2026

Granules India Limited is pleased to collaborate with the Society for Elimination of Rural Poverty (SERP), Government of Telangana, expanding its existing Corporate Social Responsibility (CSR) initiative to bring breast cancer screening and awareness to women in the rural communities of Sangareddy district.

The partnership was formalised in the presence of key dignitaries, including Ms. Divya Devarajan, IAS, CEO, SERP, Government of Telangana; Ms. P. Pravinya, IAS, Collector and District Magistrate, Sangareddy;
Mrs. Uma Chigurupati Executive Director; and Dr. Dr.Pragnya Chigurupati , Oncologist and Oncoplastic Surgeon, AIG Hospitals and Founder, UC Breast Foundation.

With the support of our healthcare partners: AIG Hospitals, Asian Medical Foundation, and UC Breast Foundation, the initiative has screened over 5,000 women and reached out to thousands of women through awareness programs since its inception in September 2024.

By combining medical expertise with SERP’s strong grassroots network, we aim to further strengthen community-level awareness, participation, and preventive care. We remain committed to advancing preventive healthcare and creating lasting impact for women and communities that need it the most.


In a conversation with CNBC TV18, our Executive Director Priyanka Chigurupati highlighted Granules India’s 28 percent ye...
27/01/2026

In a conversation with CNBC TV18, our Executive Director Priyanka Chigurupati highlighted Granules India’s 28 percent year on year increase in PAT. This growth was driven by improved capacity utilisation and the company’s continued focus on complex generics, operational efficiencies and disciplined capital allocation, all of which continue to strengthen business stability.

https://www.youtube.com/watch?v=pNmbnstU5mQ

| Granules India Posts Strong Q3FY26 ResultsExecutive Director, Priyanka Chigurupati to CNBC-TV18- Adjusted profit up 45% in Q3FY26- Want to ...

Teams across Granules India Limited’ manufacturing units came together to commemorate India’s 77th Republic Day with pri...
26/01/2026

Teams across Granules India Limited’ manufacturing units came together to commemorate India’s 77th Republic Day with pride, unity, and a deep sense of purpose.

We were honoured to have our Executive Directors, Mrs. Uma Chigurupati and Ms. Priyanka Chigurupati join the celebrations, along with our senior leaders to hoist the national flag and reaffirm our collective commitment to the values that shape our nation.

Wishing everyone a very Happy Republic Day.

Our Q3FY26 results are out – one of our strongest quarters yetClick here for more details : https://shorturl.at/WfnUe   ...
23/01/2026

Our Q3FY26 results are out – one of our strongest quarters yet
Click here for more details : https://shorturl.at/WfnUe

Granules India Limited was pleased to participate in Swiss–India business networking engagements held on the sidelines o...
23/01/2026

Granules India Limited was pleased to participate in Swiss–India business networking engagements held on the sidelines of the World Economic Forum in Davos.

Dr. Srinivas PV, Chief Technology Officer, and Mr. Sanjay Kumar, Chief Strategy Officer, represented Granules at the session on “Value Chains in Pharma and Biotech – Complementarity between India and Switzerland,” where they highlighted our 40+ year legacy and our commitment to innovation-led growth.

The event offered strong networking opportunities with canton officials, innovation hubs and incubation centres, while also reinforcing the strategic relevance of India–Switzerland collaboration in our growth roadmap. With the recent launch of Ascelis Peptides and the acquisition of Swiss-based Senn Chemicals AG, Granules continues to strengthen its future focused capabilities in peptide-based therapeutics and CDMO services.

Address

Granules India Limited 15th Floor, Granules Tower, Botanical Garden Road, Kondapur
Hyderabad
500084

Opening Hours

Monday 9am - 6pm
Tuesday 9am - 6pm
Wednesday 9am - 6pm
Thursday 9am - 6pm
Friday 9am - 6pm

Telephone

+914069043500

Alerts

Be the first to know and let us send you an email when Granules India Limited posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Granules India Limited:

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram